Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00312793
Other study ID # ST02-HMO-CTIL
Secondary ID
Status Terminated
Phase Phase 1/Phase 2
First received April 10, 2006
Last updated June 21, 2009

Study information

Verified date June 2009
Source Hadassah Medical Organization
Contact n/a
Is FDA regulated No
Health authority Israel: Israeli Health Ministry Pharmaceutical Administration
Study type Interventional

Clinical Trial Summary

This study is designed to evaluate the efficacy and safety of Myospare, a non-invasive device, which is connected to the body via electrodes placed in the injured leg. The electrodes which are placed in the middle or upper thigh will stimulate the quadriceps muscle.

Myospare will be installed 1 day after the anterior cruciate ligament (ACL) reconstruction surgery and will be removed after 6 weeks of treatment. The patients will be assigned to two groups:

1. Physiotherapy plus Myospare

2. Only physiotherapy

The hypothesis of the study is that electrical stimulation combined with voluntary exercise is more effective than voluntary exercise alone.


Recruitment information / eligibility

Status Terminated
Enrollment 60
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

1. Males and females between 18-40 years old.

2. Subjects who are planning to undergo ACL surgery.

3. The surgery is performed within 3 weeks - 5 years since the injury.

4. Ability to follow instructions during the study period.

5. Signed Informed Consent.

Exclusion Criteria:

1. Bi-lateral surgery of the knee

2. Recurrent ACL surgery (patients who already underwent ACL surgery)

3. Complex injuries (a combination of posterior and anterior cruciate and lateral ligament injury)

4. Patients who underwent or are planned to undergo cartilage implantation.

5. Patients who underwent or are planned to undergo meniscus stitching.

6. Additional fracture/s in the lower limbs as a result of the same injury.

7. Signs of infection in the surgical wounds while installing the Myospare device.

8. Known skin hypersensitivity.

9. Known heart disease

10. Patients with a cardiac pacemaker.

11. History of peripheral blood vessel disease

12. Administration of drugs which might disrupt bone metabolism:

- Total accumulating dosage of 150 gr' prednisone or any other glucocorticoid for seven days or more, within 6 months prior to the trial.

- Calcitonin for 7 days or more, within 6 months prior to the trial.

- Bisphosphonates for 30 days or more within 12 months prior to the study.

- Fluoride for bone strengthening for 30 days or more within 12 months prior to the study.

- Vitamin D or vitamin D metabolite for bone strengthening for 30 days or more within 12 months prior to the study.

- Current treatment with chemotherapeutic drugs.

13. Past or current malignant disease within 10 years of study entry.

14. Participating in another clinical study during the past four weeks.

15. Patients who are planned to undergo femoral nerve block.

16. Patients claiming social security/work accident benefits.

17. Professional athletes whose livelihood depends on sports.

18. Pregnant and or lactating women.

19. Additional symptoms, which in the doctor's opinion would prevent inclusion of the patient in the study.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
stimulation of the quadriceps muscle with Myospare


Locations

Country Name City State
Israel Asaf Ha'rofe Orthopedic Department Beer Yaacov
Israel Hadassah Orthopedic Department Jerusalem
Israel Meir Orthopedic Department Kfar Saba

Sponsors (1)

Lead Sponsor Collaborator
Hadassah Medical Organization

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary the outcome measure is muscle weakness and atrophy (after six weeks) measured by isometric device
Secondary range of movement measured by protractor
Secondary swelling measure by physical examination
Secondary stability of the knee measure by KT1000
Secondary knee history measure by IKDC2000
Secondary functional preservation measure by single hop tests and triple hop tests
See also
  Status Clinical Trial Phase
Recruiting NCT04554212 - Blood Flow Restriction Training After Patellar INStability N/A
Completed NCT04815980 - Impact of Pilates on Running Mechanics N/A
Not yet recruiting NCT05484778 - Analysis of Balance and Functional Hop Tests Used for Return to Sports in Athletes With Lower Extremity Injuries by Dual Task Study N/A
Terminated NCT02909257 - Motor-Sparing Femoral Nerve Block Dose Phase 4
Completed NCT02540811 - Clinical Evaluation of dCELL® ACL Scaffold for Reconstruction of the Anterior Cruciate Ligament N/A
Recruiting NCT03755388 - Clinical Trial of an MRI Based Patient Specific Focal Knee Resurfacing Implant N/A
Recruiting NCT00174213 - Validity and Reliability in Measuring Iliotibial Tract by Using Ultrasound Phase 1
Completed NCT03202901 - Accute Effect of B-Turmactive Both on Mild and Moderate Knee Pain on Healthy Volunteers N/A
Completed NCT06206018 - Patient-Reported Outcome Measures in Lower Extremity Rehabilitation Program PROM_R: Impact on Health Care N/A
Completed NCT04543227 - Opioid Laws and Pediatric Use
Completed NCT06078072 - Biomaterials and Mesenchymal Stem/Stromal Cells in the Treatment of Knee Articular Surface Lesions
Completed NCT04956393 - The SOAR (Stop OsteoARthritis) Program Proof-of-Concept Study N/A
Recruiting NCT06451510 - Knee Osteoarthritis in the Region of Norrbotten
Completed NCT04118023 - 7T MRI to Evaluate Cartilage Defects in the Knee
Completed NCT03486405 - A Randomized Control Trial: Returning to Run After Injury N/A
Recruiting NCT03858231 - Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery Phase 4
Recruiting NCT02918734 - Fixation of Patellar Tendon Grafts in Anterior Cruciate Ligament Reconstruction. Endobutton vs Metal Interference Screws N/A
Suspended NCT02270905 - Clinical Evaluation of dCELL® Meniscus for Partial Replacement of the Meniscus N/A
Completed NCT01227694 - Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis Phase 1/Phase 2
Completed NCT00991588 - Clinical Outcome of Posterior Cruciate Ligament (PCL) Posterolateral Reconstruction